# Icosapent Ethyl

NDC: 60505-4033
Generic name: Icosapent Ethyl
Labeler / Manufacturer: Apotex Corp
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20211216
Marketing ended: 20270831
FDA application: ANDA209437

## Active ingredients

- ICOSAPENT ETHYL: 1 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60505-4033"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60505-4033
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=886aa8d8-b293-258f-b16d-be40418787a8